Background. The Canadian province of British Columbia has experienced an ongoing heterosexual infectious syphilis epidemic since July 1997. In this study, we sought to characterize individuals who received a diagnosis of syphilis more than once in a cohort of reported cases from 1995 through 2005 in British Columbia.
have been attempted by health agencies, including the British Columbia Centre for Disease Control (Vancouver, Canada), to address the ongoing epidemic. These interventions include mass treatment with azithromycin [3, 4] , messaging campaigns, a social networking approach to contact tracing or treatment [5] , Webbased education and referral outreach, targeted community outreach for infectious syphilis in gay venues, and enhanced provincial recommendations for increased testing [6] . Despite these efforts, the province continues to experience increased rates in both heterosexual and MSM populations. The provincial syphilis outbreak team, which reviews all newly reported cases of infectious syphilis in the province, noted increasing numbers of individuals who were receiving repeated diagnoses of infectious syphilis. To understand this unique trend and its contribution to onward transmission, we conducted a study to characterize individuals who received a syphilis diagnosis more than once in a cohort of patients with reported cases of syphilis from 1995 through 2005.
PATIENTS AND METHODS

Case definition.
Infectious syphilis is diagnosed according to the Canadian Sexually Transmitted Infection (STI) Guidelines and includes a reactive rapid plasma reagin (RPR) and Treponema pallidum particle agglutination test [7] . Alternatively, a positive dark-field analysis is also indicative of syphilis. Treatment also follows Canadian STI Treatment Guidelines [7] , which recommend a single treatment with 2.4 MU of benzathine penicillin intramuscularly for those who are not allergic to penicillin. All syphilis testing in British Columbia is conducted at 1 provincial laboratory (Provincial Health Services Authority Laboratory Services).
Data sources. Data for all cases of primary, secondary, and early latent syphilis from 1 January 1995 through 31 December 2005 were extracted from the British Columbia Provincial STI Surveillance Database. This database functions as an STI electronic health record and contains all laboratory results, treatment information, and follow-up information for all reportable STIs in British Columbia, including syphilis and human immunodeficiency virus (HIV) infection.
For this analysis, individuals were included in the cohort if their first reported case of infectious syphilis occurred within the study period. Individuals were divided into 2 groups: those who had a single diagnosis of infectious syphilis and those who had у2 diagnoses of infectious syphilis during the study period. Individuals who had had a previous infection before 1 January 1995 were excluded from the analysis. Those who had their first infection within 6 weeks of 31 December 2005 were also excluded, to include only individuals who had the potential for receiving a rediagnosis of syphilis. The date of the positive RPR laboratory test result was used as the date of infection and rediagnosis. Rediagnosis of syphilis was defined as having been previously diagnosed as having syphilis, having received adequate treatment, and having demonstrated 1 of the following: (1) a 4-fold decrease in RPR titer followed by an increase between diagnoses or (2) a newly diagnosed lesion with a positive dark field or direct fluorescent antibody-T. pallidum test result. A new diagnosis was also made for individuals who did not have a recorded 4-fold decrease but who had a strong clinical history consistent with risk for reacquisition of syphilis. Patients who did not complete their initial recommended treatment and had received a second diagnosis of syphilis were not considered to have had their conditions rediagnosed. Each rediagnosis was reviewed and confirmed by a single STI clinic physician, and then recommendations for additional treatment were made.
Variables. The following variables of interest were extracted for analysis: demographic characteristics (age, sex, sexual identity, ethnicity), syphilis diagnostic characteristics (RPR at initial diagnosis, stage of syphilis, and treatment of initial syphilis infection), and risk factors (previous reportable STI, including HIV infection and drug use). Data on certain risk characteristics, such as condom use and number of sexual partners, were missing for a large number of cases and, therefore, were not included in the analysis.
Statistical analysis. A descriptive analysis was conducted for all variables from the study cohort, and the incidence density of syphilis rediagnosis was calculated. Observation time was calculated as the time from the date of an individual's first syphilis diagnosis to their first rediagnosis or to the end of the follow-up period if the individual did not receive a second diagnosis of syphilis. Bivariate analyses were conducted using Cox proportional hazards regression techniques to compare those who received a single syphillis diagnosis with those who received 11 syphillis diagnosis within the 10-year period. Variables of interest were entered individually to obtain crude hazard ratios, and those variables that reached a statistical significance level of were entered into a multivariate Cox P ! .10 regression model to estimate the adjusted relative hazard of syphilis rediagnosis over time by characteristics at initial syphilis diagnosis. Of the 1473 individuals included in the analyses, 1385 (94%; 95% confidence interval [CI], 92.7%-95.2%) had a single diagnosis of syphilis, and 88 (6.0%; 95% CI, 4.2%-7.3%) had 11 syphilis diagnosis. Among those with 11 diagnosis, 14 received 2 rediagnoses, and 2 received 3 rediagnoses. Fifty cases of rediagnosis occurred in individuals who presented with early latent syphilis at the time of their first diagnosis. Of these, 28 demonstrated a 4-fold decrease in RPR between new diagnoses, followed by an increase in RPR. Nine individuals underwent RPR testing between diagnoses, with no demonstrated 4-fold decrease. However, all of these patients had a clinical history of engaging in risk behaviors that are associated with reacquisition of syphilis. The additional 13 individuals did not have interim RPR testing but had new sexual partners and a history of risk for reacquisition that met the case definition of rediagnosis.
RESULTS
A total of 1536 individuals received a diagnosis of infectious syphilis in British
The median time between the first and second diagnoses was 15.5 months. The crude incidence of syphilis rediagnosis was 6% (95% CI, 4.8%-7.3%), and the overall incidence density of rediagnosis was 2 cases per 100 person-years. The crude incidence of syphilis rediagnosis was 8.5% (95% CI, 5.8%-11.8%) in MSM and 15.7% (95% CI, 11.1%-21.4%) in HIVpositive persons.
In bivariate analyses, sexual identity, ethnicity, HIV status, and an infection with either chlamydia or gonorrhea within the 10-year period were significantly associated with receiving a syphillis rediagnosis (table 2). In Cox proportional hazards regression analysis, the following characteristics were associated with an increased risk of becoming reinfected with syphilis:
HIV seropositivity, history of ever having gonorrhea or chlamydia, aboriginal ethnicity, and MSM sexual identity (table 2) . Age, sex, stage of syphilis at time of first diagnosis, and use of azithromycin were not associated with risk of rediagnosis of syphilis. In a sensitivity analyses, MSM, HIV status, and history of chlamydia or gonorrhea remained strongly significant in the model when we controlled for age, sex, stage of diagnosis, and drug use.
DISCUSSION
There is a continued need to more explicitly understand the role of reacquisition and rediagnoses of cases of STIs as we consider STI control policies. In this study, an increasing proportion of syphilis cases in British Columbia were attributed to a rediagnosis during the previous 10 years. In 2006, up to 10% of new cases of syphilis in British Columbia occurred in individuals who had received a previous diagnosis of syphilis. This study showed that, in the province of British Columbia, being HIV positive, having a history of ever having chlamydia or gonorrhea, being of aboriginal ethnicity, or being an MSM were independently associated with a rediagnosis of syphilis. Individuals with these characteristics may represent a core group of transmitters who continue to engage in risky behaviors and sustain the epidemic.
In this study, we chose to use the term "syphilis rediagnosis," because we discussed second (or third) cases of syphilis that required additional treatment. This term allows us to consider individuals who receive repeated diagnoses of syphilis without implying the underlying reason for the second diagnosis of syphilis. The second diagnosis could be reacquisition (or a new infection) acquired during a risk encounter, or it could represent a continued infection (i.e., failure of initial treatment). However, we also offered a clear case definition for a rediagnosis. Every individual in the study who received a second diagnosis of syphilis and subsequent therapy demonstrated a 4-fold decrease in RPR titers between diagnoses, had evidence of primary or secondary syphilis at the time of rediagnosis, or reported a risk behavior consistent with syphilis reacquisition between diagnoses. In our study, reported risk behaviors were reviewed by a syphilis team, including the same STI clinic physician and nursing supervisor who have been with the division for 120 years. However, there is a need for researchers and clinicians to adopt uniform definitions of syphilis rediagnosis and reinfection for studies in this field, to permit broader examination of this topic, and to ensure that there is shared clarity on the meaning of the term "reinfection" in syphilis.
Syphilis reinfections were examined in Lima, Peru, and a high reinfection rate (42.7%) was noted in this region [8] . In this study involving 1261 individuals, the high rates of reinfection were attributed to continued high-risk sexual behavior after treatment and limited partner notification and treatment. In this study, those who were HIV positive were successfully treated using established treatment guidelines.
In our analysis, HIV infection status was associated with a rediagnosis of syphilis. HIV infection status itself could be a marker for specific sexual behaviors, including serosorting, leading to reduced condom use and/or continued risk exposure for syphilis reacquisition after successful treatment. Alternatively, HIV itself could have an impact on the effectiveness of syphilis treatment, and rediagnoses could reflect syphilis treatment failure, although the recent study from Peru reports that the clinical response to syphilis treatment among HIV-infected individuals was comparable to the cure rate among HIV-negative individuals. As discussed earlier, improved clarity on the definition of syphilis rediagnosis or reinfection is essential for further research, as is continued examination of both the biological and behavioral role of HIV infection status in syphilis rediagnosis and treatment [8] .
As a result of centralized case reporting, laboratory testing, management, and follow-up for infectious syphilis in British Columbia, we were able to examine the characteristics of all individuals infected with infectious syphilis in British Columbia over a 10-year period. In addition, we applied a conservative approach to a rediagnosis of syphilis. Syphilis was only rediagnosed in individuals who, in addition to having received adequate initial treatment, demonstrated clinical evidence of a new case of primary or secondary or early latent syphilis. Clinical evidence consisted of an adequate (4-fold) decrease in their RPR titer between the first and second diagnoses or a strong clinical history in keeping with risk for reexposure and reacquisition of syphilis. All laboratory tests were conducted at the same laboratory during the entire period, which would limit the risk of laboratory misclassification caused by different laboratory conditions found in different laboratories.
Despite these strengths, this study possesses limitations that are essential to consider. Rediagnosis was defined for the purposes of this analysis as a 4-fold decrease in RPR titers between diagnoses, evidence of primary or secondary syphilis at the time of rediagnosis, or a reported risk behavior consistent with syphilis reacquisition between diagnoses. Thus, this definition would combine both those individuals who experienced a relapse and those who experienced a reinfection. This underscores the need for clinicians and researchers to arrive at a shared definition of relapse, compared with reinfection, to conduct specific analyses targeted to better understand the characteristics that are unique to individuals who experience relapse, compared with those of individuals who are subsequently infected. Individuals with positive test results who received a rediagnosis of syphilis outside of the province would not be included, in this study, in the rediagnosis group. Missing data related to drug use, CD4 + cell count, and condom use limited our ability to measure the association between these important variables and rediagnosis of syphilis. Finally, although there is centralized HIV testing in the province, HIV-positive individuals who have never been tested for HIV or who received positive test results outside of the province could not be included in the model that includes HIV infection status.
Authors have reported increased rates of reinfection with chlamydia, gonorrhea, and trichomoniasis and have described the characteristics of individuals who experience reinfection with these STIs. In several of these studies, sexual identity [9, 10] , cultural background [9] [10] [11] , and having a previous STI [11, 12] also emerged as significant predictors of reinfection. However, other studies have identified other predictors of reinfection, including age [10] , number of sexual partners [13] , risky sexual partners [13, 14] , and failure to use condoms. Beyond the behavioral and epidemiologic basis for increasing rates of reinfection with STIs, there is also an emerging literature that explores possible biological explanations for these increasing rates. In their study that examined chlamydia reinfection rates, Brunham et al. [15] proposed altered immunity as the underpinning factor of the increasing number of cases of chlamydia reinfection in British Columbia. Because of the likely critical role played by those with reinfection in maintaining and propagating our current STI epidemic(s), there is a need to better characterize individuals with reinfections, understand the biological underpinnings of this phenomenon, and implement and evaluate interventions designed to decrease rates of subsequent infections as part of sexually transmitted disease control policies.
